Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MTP Orthopedic is a regenerative medicine product developed by FetTech, utilizing their proprietary Multi-Tissue Platform (MTP®). It is an extracellular matrix (ECM)-based therapy designed to treat orthopedic conditions, specifically knee osteoarthritis. The product provides a natural scaffold and biological signaling environment that provides the body with the tools and instructions needed to repair and regenerate damaged joint tissues and cartilage. Derived from natural sources, MTP Orthopedic aims to restore joint function by leveraging the body's innate healing mechanisms rather than relying on synthetic materials or traditional pharmacological agents. It is currently in the preclinical/pipeline stage of development, with the company seeking partnerships for further clinical advancement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MTP Orthopedic.